Meenhard Herlyn Selected Research

alpha-2'-deoxythioguanosine

12/2021	A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas.
10/2018	Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meenhard Herlyn Research Topics

Disease

182	Melanoma (Melanoma, Malignant) 01/2022 - 01/2002
161	Neoplasms (Cancer) 01/2022 - 01/2002
26	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2002
9	Carcinogenesis 01/2021 - 01/2003
6	Disease Progression 01/2021 - 01/2005
5	Inflammation (Inflammations) 01/2022 - 01/2003
5	Esophageal Squamous Cell Carcinoma 01/2012 - 02/2007
4	Hypoxia (Hypoxemia) 12/2017 - 03/2005
3	Nevus (Nevi) 12/2018 - 09/2012
3	Genomic Instability 01/2017 - 04/2005
3	Wounds and Injuries (Trauma) 12/2012 - 09/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012 - 01/2002
3	Hyperplasia 01/2012 - 01/2002
2	Glioma (Gliomas) 01/2022 - 12/2021
2	Testicular Neoplasms (Testicular Cancer) 10/2020 - 05/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 12/2002
2	Squamous Cell Carcinoma of Head and Neck 12/2013 - 07/2004

Drug/Important Bio-Agent (IBA)

36	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
27	Pharmaceutical PreparationsIBA 01/2021 - 09/2006
26	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 02/2003
23	Biological ProductsIBA 01/2022 - 02/2002
15	Cadherins (E-Cadherin)IBA 01/2018 - 01/2004
14	Mitogen-Activated Protein KinasesIBA 07/2016 - 01/2002
12	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 02/2002
11	Immune Checkpoint InhibitorsIBA 01/2022 - 03/2016
11	Phosphotransferases (Kinase)IBA 01/2020 - 12/2002
10	VemurafenibIBA 05/2019 - 10/2010
9	LigandsIBA 01/2022 - 09/2003
8	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2007
8	Cyclin D1IBA 11/2013 - 06/2002
7	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2003
7	CytokinesIBA 01/2018 - 02/2002
6	CollagenIBA 01/2022 - 05/2005
6	AntigensIBA 10/2020 - 06/2003
5	RNA (Ribonucleic Acid)IBA 12/2021 - 04/2017
5	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 12/2002
5	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017 - 04/2003
5	Protein Kinases (Protein Kinase)IBA 12/2016 - 10/2002
4	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2015
4	ChemokinesIBA 12/2021 - 05/2003
4	Protein Isoforms (Isoforms)IBA 12/2019 - 12/2010
4	Complementary DNA (cDNA)IBA 05/2016 - 01/2002
4	Interleukin-8 (Interleukin 8)IBA 05/2016 - 02/2002
4	IntegrinsIBA 03/2014 - 06/2005
3	ProdrugsIBA 01/2022 - 12/2017
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 07/2004
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 05/2006
3	Small Interfering RNA (siRNA)IBA 11/2020 - 12/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 11/2017
3	LipidsIBA 01/2020 - 05/2008
3	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 11/2005
3	EnzymesIBA 01/2018 - 09/2003
3	Adenosine Triphosphate (ATP)IBA 07/2017 - 06/2012
3	PLX 4720IBA 06/2017 - 02/2008
3	MicroRNAs (MicroRNA)IBA 04/2017 - 11/2011
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017 - 02/2002
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2016 - 09/2003
3	ErbB Receptors (EGF Receptor)IBA 05/2016 - 01/2003
3	AntibodiesIBA 03/2016 - 01/2015
3	Chemokine ReceptorsIBA 09/2015 - 05/2005
3	Peptides (Polypeptides)IBA 01/2015 - 08/2005
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2013 - 09/2007
3	Cisplatin (Platino)FDA LinkGeneric 06/2013 - 09/2003
3	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 02/2012 - 05/2006
3	Histones (Histone)IBA 10/2010 - 04/2003
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2010 - 11/2005
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2010 - 04/2006
2	Therapeutic UsesIBA 01/2022 - 12/2017
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2012
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2022 - 04/2017
2	PlasticsIBA 01/2022 - 12/2005
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 12/2021
2	NucleosidesIBA 12/2021 - 10/2018
2	alpha-2'-deoxythioguanosineIBA 12/2021 - 10/2018
2	Imatinib Mesylate (Gleevec)FDA Link 12/2021 - 07/2008
2	Sunitinib (Sutent)FDA Link 12/2021 - 12/2017
2	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021 - 10/2002
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 11/2017
2	VimentinIBA 01/2020 - 06/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2019 - 11/2017
2	Endoplasmic Reticulum Chaperone BiPIBA 01/2019 - 03/2014
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2018 - 11/2007
2	ChromatinIBA 01/2018 - 03/2015
2	Drug CombinationsIBA 01/2018 - 01/2008
2	CateninsIBA 11/2017 - 09/2012
2	CyclinsIBA 01/2017 - 07/2008
2	Caspase 3 (Caspase-3)IBA 09/2015 - 09/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2015 - 01/2003
2	GalactosidasesIBA 03/2015 - 09/2012
2	IpilimumabIBA 01/2015 - 03/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 06/2013
2	Interleukin-1 (Interleukin 1)IBA 01/2015 - 09/2012
2	NivolumabIBA 01/2015 - 01/2015
2	Conditioned Culture MediaIBA 04/2014 - 07/2012
2	Chemotactic FactorsIBA 04/2014 - 01/2003

Therapy/Procedure

113	Therapeutics 01/2022 - 10/2002
16	Immunotherapy 01/2022 - 07/2002
9	Drug Therapy (Chemotherapy) 02/2020 - 11/2005
2	Heterologous Transplantation (Xenotransplantation) 01/2019 - 03/2008
2	Artificial Skin 09/2016 - 06/2009